Content

Events
About

The Zebrafish (Danio rerio) In Vivo Model for Preclinical Toxicity Testing

Zebrafish: The alternative vertebrate animal model

The zebrafish is emerging as a complement to existing in vitro technologies and established preclinical in vivo models that can be scaled for high throughput. Technological innovation has helped the zebrafish embryo gain ground as a disease model and an assay system for drug screening.  

Have Your Say
Rate this feature and give us your feedback in the comments section below

Download PDF Attachment

Upcoming Events


DigIT Pharma 2026 | AI Commercial, Medical & Patient Care

September 9 - 10, 2026
Steigenberger Airport Hotel Berlin, Deutschland
Register Now | View Agenda | Learn More


Pharmaceutical Launch Excellence Summit US

September 30 - October 1, 2026
Hyatt Regency Boston Harbor, Boston, US
Register Now | View Agenda | Learn More


Pharmaceutical Launch Excellence Summit

1 - 3 December, 2026
Novotel Amsterdam City, Netherlands
Register Now | View Agenda | Learn More

MORE EVENTS